4/5
08:08 am
akya
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale [Yahoo! Finance]
Medium
Report
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale [Yahoo! Finance]
4/5
08:00 am
akya
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
Medium
Report
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
3/19
07:06 am
akya
Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider [Yahoo! Finance]
Low
Report
Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider [Yahoo! Finance]
3/19
07:00 am
akya
Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider
Low
Report
Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider
3/6
11:58 am
akya
Akoya Biosciences, Inc. (NASDAQ: AKYA) had its price target lowered by analysts at JPMorgan Chase & Co. from $12.00 to $10.00. They now have an "overweight" rating on the stock.
Low
Report
Akoya Biosciences, Inc. (NASDAQ: AKYA) had its price target lowered by analysts at JPMorgan Chase & Co. from $12.00 to $10.00. They now have an "overweight" rating on the stock.
3/5
10:35 am
akya
Akoya Biosciences, Inc. (NASDAQ: AKYA) had its price target raised by analysts at UBS Group AG from $7.00 to $7.50. They now have a "buy" rating on the stock.
Medium
Report
Akoya Biosciences, Inc. (NASDAQ: AKYA) had its price target raised by analysts at UBS Group AG from $7.00 to $7.50. They now have a "buy" rating on the stock.
3/5
10:11 am
akya
Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/5
09:11 am
akya
Akoya Biosciences, Inc. (NASDAQ: AKYA) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $10.00 price target on the stock.
High
Report
Akoya Biosciences, Inc. (NASDAQ: AKYA) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $10.00 price target on the stock.
3/4
07:08 pm
akya
Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
High
Report
Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
3/4
05:41 pm
akya
Akoya Biosciences Inc (AKYA) Reports Record Q4 Revenue and Sets Positive 2024 Outlook [Yahoo! Finance]
High
Report
Akoya Biosciences Inc (AKYA) Reports Record Q4 Revenue and Sets Positive 2024 Outlook [Yahoo! Finance]
3/4
04:22 pm
akya
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook [Yahoo! Finance]
High
Report
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook [Yahoo! Finance]
3/4
04:05 pm
akya
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
High
Report
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
2/24
08:18 am
akya
Akoya Biosciences Insiders Placed Bullish Bets Worth US$2.11m [Yahoo! Finance]
Medium
Report
Akoya Biosciences Insiders Placed Bullish Bets Worth US$2.11m [Yahoo! Finance]
2/8
04:05 pm
akya
Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference
Low
Report
Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference
2/7
05:35 am
akya
Strength Seen in Akoya (AKYA): Can Its 7.4% Jump Turn into More Strength? [Yahoo! Finance]
Low
Report
Strength Seen in Akoya (AKYA): Can Its 7.4% Jump Turn into More Strength? [Yahoo! Finance]